Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery

Topical ocular administration is the most convenient route of administration of drugs for the treatment of eye diseases. However, the bioavailability of drugs following eye instillations of eye drops is very low. Over the past 20 years, extensive efforts have been put into research to improve drug bioavailability without compromising treatment compliance and patients' quality of life.

• Publication year

  2013

• Venue

  The Journal of pharmacy and pharmacology

• Publication date

  2013-05-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/jphp.12075PMID 24001405PMCID 4283994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping

  2016cited by this paper
• Distribution of Cyclosporine A in Ocular Tissues After Topical Administration of Cyclosporine A Cationic Emulsions to Pigmented Rabbits

  2013cited by this paper
• The Influence of Seasonality and Subtype in Vernal Keratoconjunctivitis (VKC) Patients in a Randomized Clinical Trial Investigating NOVA22007, a preservative-free cyclosporine cationic emulsion

  2012cited by this paper
• Comparison of the anti‐inflammatory effects of artificial tears in a rat model of corneal scraping

  2012cited by this paper
• A Comparative Study of a Preservative-Free Latanoprost Cationic Emulsion (Catioprost) and a BAK-Preserved Latanoprost Solution in Animal Models

  2012cited by this paper
• Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb

  2012cited by this paper
• Controlled and continuous release ocular drug delivery systems: pros and cons.

  2012cited by this paper
• Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model

  2012cited by this paper
• In Vitro and In Vivo Evaluation of a Preservative-Free Cationic Emulsion of Latanoprost in Corneal Wound Healing Models

  2012cited by this paper
• Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines

  2011cited by this paper
• Wound Healing Models

  2011cited by this paper
• The effect of Vekacia® (unpreserved cyclosporine cationic emulsion) on severe corneal involvement in patients with vernal keratoconjunctivitis participating in a randomized, parallel group controlled, clinical trial

  2011cited by this paper
• Ocular drug delivery – a look towards nanobioadhesives

  2011cited by this paper
• In Vitro Toxicity of Topical Ocular Prostaglandin Analogs and Preservatives on Corneal Epithelial Cells

  2010cited by this paper
• Preservatives in eyedrops: the good, the bad and the ugly.

  2010cited by this paper
• Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells

  2010cited by this paper
• Determining the cytotoxicity of catanionic surfactant mixtures on HeLa cells.

  2009cited by this paper
• Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay

  2009cited by this paper
• Preservatives in topical ophthalmic medications: historical and clinical perspectives

  2009cited by this paper
• Conjunctival modifications in ocular hypertension and primary open angle glaucoma: an in vivo confocal microscopy study.

  2008cited by this paper
• Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma

  2008cited by this paper
• Glycan structures of ocular surface mucins in man, rabbit and dog display species differences

  2008cited by this paper
• Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits

  2008influential reference
• Ocular Symptoms and Signs with Preserved and Preservative-Free Glaucoma Medications

  2007cited by this paper
• Challenges and obstacles of ocular pharmacokinetics and drug delivery.

  2006influential reference
• Hyperosmolar Saline Is a Proinflammatory Stress on the Mouse Ocular Surface

  2005cited by this paper
• The potential of lipid emulsion for ocular delivery of lipophilic drugs.

  2004cited by this paper
• Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells.

  2004cited by this paper
• Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study.

  2004cited by this paper
• Vesicular systems in ocular drug delivery: an overview.

  2004cited by this paper
• Extensive surface studies help to analyse zeta potential data: the case of cationic emulsions.

  2004cited by this paper
• Cationic Vectors in Ocular Drug Delivery

  2004cited by this paper
• Comparison of the Short-Term Effects on the Human Corneal Surface of Topical Timolol Maleate With and Without Benzalkonium Chloride

  2003cited by this paper
• Ocular tolerance of preservatives and alternatives.

  2002influential reference
• Method for the measurement of the diffusion coefficient of benzalkonium chloride.

  2002cited by this paper
• Physicochemical screening of antimicrobial agents as potential preservatives for submicron emulsions.

  2002cited by this paper
• Microemulsions as ocular drug delivery systems: recent developments and future challenges.

  2002cited by this paper
• Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis.

  2002cited by this paper
• Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells.

  2001cited by this paper
• Ocular delivery of cyclosporin A. I. Design and characterization of cyclosporin A-loaded positively-charged submicron emulsion

  2001cited by this paper
• Ocular delivery of cyclosporin A. II. Effect of submicron emulsion's surface charge on ocular distribution of topical cyclosporin A

  2001cited by this paper
• Influence of Emulsion Droplet Surface Charge on Indomethacin Ocular Tissue Distribution

  2000cited by this paper
• Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers

  1998cited by this paper
• Influence of Interfacial Properties of Lipophilic Surfactants on Water-in-Oil Emulsion Stability

  1998cited by this paper
• Anti‐inflammatory activity of cationic lipids

  1997cited by this paper
• Formulation and physical characterization of water-in-oil microemulsions containing long- versus medium-chain glycerides

  1997cited by this paper
• The stability of piroxicam incorporated in a positively-charged submicron emulsion for ocular administration

  1996cited by this paper
• Pilocarpine Incorporated into a Submicron Emulsion Vehicle Causes an Unexpectedly Prolonged Ocular Hypotensive Effect in Rabbits

  1994cited by this paper
• Physicochemical Characterization and Acute Toxicity Evaluation of a Positively‐charged Submicron Emulsion Vehicle

  1994cited by this paper
• PRESERVATIVE REQUIREMENTS IN EMULSIONS

  1992cited by this paper
• A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits.

  1992cited by this paper
• The influence of charged lipids on the flocculation and coalescence of oil-in-water emulsions. I: Kinetic assessment of emulsion stability.

  1990cited by this paper
• Toxicity of some charged lipids used in liposome preparations.

  1983cited by this paper
• Toxicity of some charged lipids used in liposome preparations.

  1983cited by this paper
• Zeta potential in colloid science. Principles and applications

  1982cited by this paper
• Preservation of solubilized and emulsified systems I: Correlation of mathematically predicted preservative availability with antimicrobial activity.

  1978cited by this paper
• Emulsions in theory and practice.

  1960cited by this paper

• Dual-functional nanoparticle formulations for simultaneous intraocular pressure reduction and neuroprotection in glaucoma: a review.

  2026cites this paper
• Biocompatible pickering emulsions stabilized by spirulina protein isolate/A-type gelatin composite particles for enhanced topical delivery

  2026cites this paper
• Cetalkonium Chloride Induced a Dose-Dependent Toxicity on Corneal Endothelial Cells.

  2025cites this paper
• The Role of Topical Cyclosporine A in Ocular Surface Inflammatory Disorders

  2025cites this paper
• Cyclosporine a in the treatment of dry eye disease: a narrative review

  2025cites this paper
• Novel treatments for bacterial keratitis: A review.

  2025cites this paper
• Nanoemulsions Based Therapeutic Strategies: Enhancing Targeted Drug Delivery against Breast Cancer Cells

  2025cites this paper
• The evolving role of ciclosporin in the management of vernal keratoconjunctivitis

  2025cites this paper
• Transfersomes: a next-generation drug delivery system for topical ocular drug delivery

  2025cites this paper
• Simvastatin is delivered to the brain by high-strength intranasal cationic SMEDDS and nanoemulsions

  2025cites this paper
• Nanotechnology-based non-invasive strategies in ocular therapeutics: Approaches, limitations to clinical translation, and safety concerns.

  2025cites this paper
• Effectiveness of 0.1% Cyclosporine a Cationic Emulsion for Treating Dry Eye Disease After Cataract Surgery Analyzed Using a Placido Tear Film Analyzer

  2025cites this paper
• A phase III study comparing preservative-free latanoprost eye drop emulsion with preserved latanoprost in open-angle glaucoma or ocular hypertension

  2025cites this paper
• Implications of nanotechnology for the treatment of Dry Eye Disease: Recent advances.

  2025cites this paper
• In vitro biophysical and biological profiling of commercial lipid-based dry eye products.

  2025cites this paper
• Recent Advances in Cationic Nanoemulsions for Drug Delivery: Preparation, Properties, and Applications.

  2025cites this paper
• In Vitro Toxicity of Cetalkonium Chloride on Corneal Epithelial Cells

  2025influential citation
• Clinical efficacy of 0.1% cyclosporine A in dry eye patients with inadequate responses to 0.05% cyclosporine A: a switching, prospective, open-label, multicenter study

  2025influential citation
• Advances in the management of ocular anterior segment diseases using biomaterials-based drug delivery systems

  2025cites this paper
• Recent Advances in Nanotechnology for the Treatment of Dry Eye Disease

  2024cites this paper
• Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders

  2024cites this paper
• Nano-based drug delivery systems for the treatment of non-infectious uveitis

  2024cites this paper
• Combination of PEGylation and Cationization on Phospholipid-Coated Cyclosporine Nanosuspensions for Enhanced Ocular Drug Delivery.

  2024cites this paper
• Therapeutic effect and mechanism of action of pterostilbene nano drugs in dry eye models.

  2024cites this paper
• Recent progress of nanomedicine in managing dry eye disease

  2024cites this paper
• Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases

  2023cites this paper
• Nanotechnology-based ocular drug delivery systems: recent advances and future prospects

  2023cites this paper
• Cationic nanoemulsion vs. 0.15% sodium hyaluronate artificial tears in the healing process following modern surface keratorefractive surgery

  2023cites this paper
• Use of a Cationic Emulsion of Latanoprost to Treat Glaucoma Patients with Ocular Surface Disease: A Preclinical Review

  2023cites this paper
• Influence of BAKs on Tear Film Lipid Layer: in vitro and in silico models.

  2023cites this paper
• A quality by design approach for the synthesis of palmitoyl-L-carnitine-loaded nanoemulsions as drug delivery systems

  2023cites this paper
• Research progress of ophthalmic preparations of immunosuppressants

  2023cites this paper
• Microscopic and Biopharmaceutical Evaluation of Emulsion and Self-Emulsifying Oil with Cyclosporine

  2023cites this paper
• Comparison of the Effects of 0.05% and 0.1% Cyclosporine for Dry Eye Syndrome Patients after Cataract Surgery

  2023cites this paper
• Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape.

  2023cites this paper
• Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis.

  2023cites this paper
• Nanoemulsions of Polyoxyethylene(4) Lauryl Ether with Solubilized Chlorhexidine Base

  2023cites this paper
• Assessment of the efficacy of 0.1% cyclosporine A cationic emulsion in the treatment of dry eye disease during COVID-19 pandemic

  2023cites this paper
• Drug-Loaded Polymeric Particulated Systems for Ophthalmic Drugs Release

  2022cites this paper
• Novel drug delivery systems for the management of dry eye.

  2022cites this paper
• In Vitro Corneal and Conjunctival Wound-Healing Assays as a Tool for Antiglaucoma Prostaglandin Formulation Characterization.

  2022influential citation
• In Vitro Evaluation of Curcumin- and Quercetin-Loaded Nanoemulsions for Intranasal Administration: Effect of Surface Charge and Viscosity

  2022cites this paper
• Curcumin and Quercetin-Loaded Lipid Nanocarriers: Development of Omega-3 Mucoadhesive Nanoemulsions for Intranasal Administration

  2022cites this paper
• Ocular drug delivery systems

  2021cites this paper
• Ocular surface response of two preservative-free cylcosporine A emulsion eye drops in a mouse model of dry eye

  2021cites this paper
• The Impact of Nanoparticles on the Immune System: A Gray Zone of Nanomedicine

  2021cites this paper
• Contributing Factors Affecting Ocular Discomfort on Instillation and Compliance of 0.1% Cyclosporine A Cationic Nanoemulsion

  2021cites this paper
• Review of Preclinical Outcomes of a Topical Cationic Emulsion of Cyclosporine A for the Treatment of Ocular Surface Diseases

  2021cites this paper
• Recent Advances in the Excipients Used for Modified Ocular Drug Delivery

  2021cites this paper
• Efficacy of Switching from Cyclosporine A 0.05% Anionic Emulsion to Cyclosporine A 0.1% Cationic Emulsion in Patients with Dry Eye Associated with Sjögren's Syndrome

  2021cites this paper
• Ophthalmic Nanoemulsions: From Composition to Technological Processes and Quality Control

  2021cites this paper
• Formulation and optimization of cationic nanoemulsions for enhanced ocular delivery of dorzolamide hydrochloride using Box-Behnken design: In vitro and in vivo assessments

  2021cites this paper
• Emulsions for Topical Eye Delivery: State of the Art and Future Perspectives

  2021cites this paper
• Compounded medications for ocular surface disease

  2021cites this paper
• A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances

  2021cites this paper
• Les traitements anti-inflammatoires dans la sècheresse oculaire

  2020cites this paper
• DEVELOPMENT OF NANOEMULSION TO IMPROVE THE OCULAR BIOAVAILABILITY AND PATIENT COMPLIANCE IN POSTOPERATIVE TREATMENT USING INDOMETHACIN

  2020cites this paper
• Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease

  2020cites this paper
• Les substituts lacrymaux

  2020cites this paper
• Effects of Aqueous-Supplementing Artificial Tears in Wearers of Biweekly Replacement Contact Lenses vs Wearers of Daily Disposable Contact Lenses

  2020cites this paper
• The Role Of Nano- Ophthalmology In Treating Dry Eye Disease.

  2020cites this paper
• The prominence of the dosage form design to treat ocular diseases.

  2020cites this paper
• Why Chain Length of Hyaluronan in Eye Drops Matters

  2020cites this paper
• Mixed Micellar Solutions of Hexadecylpiperidinium Surfactants and Tween 80: Aggregation Behavior and Solubilizing Properties

  2020cites this paper
• Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery.

  2020cites this paper
• Soft nanocarriers for new poorly soluble conjugate of pteridine and benzimidazole: Synthesis and cytotoxic activity against tumor cells

  2020cites this paper
• Nanoemulsions as Ophthalmic Drug Delivery Systems

  2020cites this paper
• FDA breakthrough—Drug therapy designations for clinical evidence

  2020cites this paper
• Advancements in sterile products and admixtures

  2020cites this paper
• A Comprehensive Review of the Clinical Trials Conducted for Dry Eye Disease and the Impact of the Vehicle Comparators in These Trials

  2020cites this paper
• Mucolytic self-emulsifying drug delivery systems (SEDDS) containing a hydrophobic ion-pair of proteinase.

  2020cites this paper
• A Review on the Fate of Legacy and Alternative Antimicrobials and Their Metabolites during Wastewater and Sludge Treatment

  2020cites this paper
• Formulation and evaluation of self-nanoemulsifying drug delivery system of brigatinib: Improvement of solubility, in vitro release, ex-vivo permeation and anticancer activity

  2020cites this paper
• Cationic Nanoemulsions with Prolonged Retention Time as Promising Carriers for Ophthalmic Delivery of Tacrolimus.

  2020cites this paper
• Stimulation of Basal Secretion in the Treatment of Dry Eye Syndrome

  2019cites this paper
• Стимуляция базальной секреции в лечении синдрома «сухого глаза»

  2019cites this paper
• Extended delivery of non-steroidal anti-inflammatory drugs through contact lenses loaded with Vitamin E and cationic surfactants.

  2019cites this paper
• Effect of a Cationic Surfactant on Microemulsion Globules and Drug Release from Hydrogel Contact Lenses

  2019influential citation
• Application of Technetium 99 Metastable Radioactive Nanosystems: Nanoparticles, Liposomes, and Nanoemulsion for Biomedical Application

  2019cites this paper
• Self-assembly of mixed systems based on nonionic and carbamate-bearing cationic surfactants as a tool for fabrication of biocompatible nanocontainers

  2019cites this paper
• Microencapsulation of cationic antimicrobial surfactants in core-shell particles

  2019cites this paper
• Binding ability of sodium valproate with cationic surfactants and effect on micellization: calorimetric, surface tension, light scattering and spectroscopic approach

  2019cites this paper
• Functional ibuprofen-loaded cationic nanoemulsion: development and optimization for dry eye disease treatment.

  2019cites this paper
• Nontoxic antimicrobial micellar systems based on mono- and dicationic Dabco-surfactants and furazolidone: Structure-solubilization properties relationships

  2019cites this paper
• Dual Drug-Loaded Electrospun Nanofibres for the Treatment of Corneal Diseases

  2019cites this paper
• Liposomas y polímeros bioadhesivos para el tratamiento de la enfermedad del ojo seco

  2019cites this paper
• Bio-adhesive polymers containing liposomes for DED treatment

  2019cites this paper
• Polyelectrolyte nanocontainers: Controlled binding and release of indomethacin

  2018cites this paper
• Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies

  2018cites this paper
• Therapeutic challenges in ocular delivery of lipid based emulsion

  2018cites this paper
• [Secondary dry eye syndrome after keratorefractive surgeries and approaches to its treatment and prevention].

  2018cites this paper
• Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas

  2018cites this paper
• Directing the nanoparticle formation by the combination with small molecular assembly and polymeric assembly for topical suppression of ocular inflammation

  2018cites this paper
• Anti-inflammatory activity of CKC-containing cationic emulsion eye drop vehicles

  2018cites this paper
• Impact of Ocular Compatible Lipoids and Castor Oil in Fabrication of Brimonidine Tartrate Nanoemulsions by 33 Full Factorial Design.

  2018cites this paper
• Mixed systems based on the cationic surfactant with a butyl carbamate fragment and nonionic surfactant Tween 80: Aggregation behavior and solubilization properties

  2018cites this paper
• Evaluating the novel application of cyclosporine 0.1% in ocular surface disease

  2018cites this paper
• Non-invasive strategies for targeting the posterior segment of eye.

  2017cites this paper
• Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts

  2017cites this paper
• Novasorb ® Cationic Nanoemulsion and Latanoprost: The Ideal Combination for Glaucoma Management?

  2017cites this paper